Abstract
In 2019 the COVID-19 pandemic, caused by SARS-CoV-2, demonstrated the urgent need for rapid, reliable, and portable diagnostics. The COVID-19 pandemic was declared in January 2020 and surges of the outbreak continue to reoccur. It is clear that early identification of infected individuals, especially asymptomatic carriers, plays a huge role in preventing the spread of the disease. The current gold standard diagnostic for SARS-CoV-2 is quantitative reverse transcription polymerase chain reaction (qRT-PCR) test based on the detection of the viral RNA. While RT-PCR is reliable and sensitive, it requires expensive centralized equipment and is time consuming (∼2 h or more); limiting its applicability in low resource areas. The FDA issued Emergency Use Authorizations (EUAs) for several COVID-19 diagnostics with an emphasis on point-of care (PoC) testing. Numerous RT-PCR and serological tests were approved for use at the point of care. Abbott’s ID NOW, and Cue Health’s COVID-19 test are of particular interest, which use isothermal amplification methods for rapid detection in under 20 min. We look to expand on the range of current PoC testing platforms with a new rapid and portable isothermal nucleic acid detection device. We pair reverse transcription loop mediated isothermal amplification (RT-LAMP) with a particle imaging technique, particle diffusometry (PD), to successfully detect SARS-CoV-2 in only 35 min on a portable chip with integrated heating. A smartphone device is used to image the samples containing fluorescent beads post-RT-LAMP and correlates decreased diffusivity to positive samples. We detect as little as 30 virus particles per μL from a RT-LAMP reaction in a microfluidic chip using a portable heating unit. Further, we can perform RT-LAMP from a diluted unprocessed saliva sample without RNA extraction. Additionally, we lyophilize SARS-CoV-2-specific RT-LAMP reactions that target both the N gene and the ORF1ab gene in the microfluidic chip, eliminating the need for cold storage. Our assay meets specific target product profiles outlined by the World Health Organization: it is specific to SARS-CoV-2, does not require cold storage, is compatible with digital connectivity, and has a detection limit of less than 35 × 10 4 viral particles per mL in saliva. PD-LAMP is rapid, simple, and attractive for screening and use at the point of care.
Keywords: Diagnostic; Loop-mediated isothermal amplification; Particle diffusometry; SARS-CoV-2; Smartphone; rapid detection.
【저자키워드】 SARS-CoV-2, diagnostic, Loop-mediated isothermal amplification, Smartphone, Particle diffusometry, rapid detection., 【초록키워드】 COVID-19, serological test, Saliva, equipment, COVID-19 pandemic, qRT-PCR, point of care, RT-PCR, FDA, diagnostics, Particle, Spread, RNA extraction, polymerase chain reaction, nucleic acid, RT-LAMP, Serological tests, Nucleic acid detection, Loop-mediated isothermal amplification, outbreak, Smartphone, Asymptomatic carriers, gold, reverse transcription, isothermal amplification, Viral RNA, N gene, resource, Quantitative, Care, platform, ORF1ab gene, Detection limit, Emergency, isothermal, COVID-19 test, Abbott, Health Organization, Chain Reaction, World Health Organization, reaction, profile, infected individuals, gold standard, applicability, authorization, positive, while, viral particle, isothermal amplification methods, fluorescent beads, polymerase chain, detect, caused, the disease, approved, virus particle, less, demonstrated, expand, eliminating, Numerous, fluorescent bead, isothermal amplification method, meet, outlined,